期刊文献+

胃癌组织和正常胃小凹上皮中抑癌基因E-cadherin hMLH1 APC和MGMT的过甲基化 被引量:9

Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium
原文传递
导出
摘要 目的探讨胃癌组织和癌旁正常胃小凹上皮中抑癌基因启动子区的甲基化状况。方法采用甲基化特异性PCR(MSP)方法,检测106例手术切除胃癌石蜡标本的胃癌组织和癌旁正常胃小凹上皮中E-cadherin、hMLH1、APC和MGMT4个抑癌基因启动子区的甲基化状态。结果在胃癌组织中,有1个以上基因甲基化者占72.6%;在正常胃小凹上皮中,有1个以上基因甲基化者占44.3%,二者差异有统计学意义(P<0.01)。甲基化与胃癌组织的Lauren分型、分化程度和pTNM分期均有关(P<0.05),但与Ming's分型无关(P>0.05)。结论E-cadherin、hMLH1、APC和MGMT基因启动子区甲基化普遍存在于胃癌组织和癌旁正常胃小凹上皮中,可能是胃癌发生发展的早期事件。 Objective To study the promoter hypermethylation of several tumor suppressor genes in gastric carcinoma (GC) tissue and adjacent normal gastric foveolar epithelium (GFE). Methods Methylation specific PCR (MSP) was used to examine the promoter methylation of tumor suppressor genes E-cadherin, hMLHI, APC and MGMT in paraffin-embedded gastric cancer tissue and adjacent normal foveolar epithelium in 106 cases. Results The positive rate of genes promoter methylation was 44.3% (47/106 cases) and 72.6% (77/106 cases) at one or more genes tested in the normal GFE and GC tissue, respectively. There was a significant difference in the positive rates of gene promoter methylation between normal GFE and GC tissue ( P = 0. 0001 ). There was a significant association with Laurén classification, degree of differentiation and pTNM staging in GC (P 〈 0.05 ), but no significant association with Ming's classification (P 〉 0.05 ). Conclusion Tumor suppressor genes promoter methylation is frequently present in GC and adjacent normal gastric foveolar epithelium, especially in Laurén diffuse type GC, poorly differentiated GC, mucus-secreting (signet ring) cell GC and pTNM stage Ⅲ and Ⅳ GC. Our findings indicate that the gene promoter methylation is a common and early event in GC carcinogensis.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2007年第7期510-513,共4页 Chinese Journal of Oncology
基金 厦门市科技基金资助项目(3502220052032) 厦门市卫生局重点科研基金资助项目(WSK0502)
关键词 表观遗传学 甲基化 胃肿瘤 抑癌基因 Epigenetics Methylation Stomach neopoalsms Tumor suppressor gene
  • 相关文献

参考文献13

  • 1Wolffe AP, Matzke MA. Epigenetics: regulation through repression.Science, 1999, 286:481-486.
  • 2Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet, 2000, 16:168-174.
  • 3Shim YH, Kang GH, Ro JY. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Investig, 2000, 80:689-695.
  • 4Leung WK, Yu J, Ng EK, et al. Concurrent hypermethylation of multiple tumor-related genes in gastric cancer and adjacent normal tissues. Cancer, 2001, 91:2294-2301.
  • 5Fukai K, Yokosuka O, Imazeki F, et al. Methylation status of pl4ARF, plSINK4b, and pl61NK4a genes in human hepatocellular carcinoma. Liver Int, 2005, 25:1209-1216.
  • 6Graziano F, Arduini F, Ruzzo A, et al. Combined analysis of Ecadherin gene ( CDH1 ) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol, 2004, 15:489-492.
  • 7张功员,马春晓,刘秋亮,乐晓平,丁一,张钦宪.食管癌组织中hMSH2基因启动子区甲基化检测[J].中华肿瘤杂志,2005,27(9):541-543. 被引量:12
  • 8马琳,张军航,刘芙蓉,张学.卵巢上皮性恶性肿瘤组织RASSF1A基因启动子区甲基化的研究[J].中华肿瘤杂志,2005,27(11):657-659. 被引量:8
  • 9Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene, 2001, 20:1525-1528.
  • 10Tamura G, Yin J, Wang S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst, 2000, 92:569-573.

二级参考文献24

  • 1张功员,刘秋亮,马春晓,乐晓平,葛秀峰,丁一,张钦宪.食管癌组织中hMSH2基因的表达[J].第一军医大学学报,2004,24(6):662-664. 被引量:5
  • 2Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet, 2001,10:735-740.
  • 3Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA,1998, 95:6870-6875.
  • 4Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res, 1998,4:1-6.
  • 5Leach FS,Nicolaides NC, Papadopoulous N, et al. Mutations of a mutS homolog in HNPCC. Cell, 1993,75:1215-1225.
  • 6Ouyang H, Shiwaku HO, Hagiwara H, et al. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach and colorectum. Cancer Res, 1997, 57:1851-1854.
  • 7Ng HH, Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev,1999, 9:158-163.
  • 8Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.Cell, 1999,99:247-257.
  • 9Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.Nat Genet, 2000,25: 315-319.
  • 10Dammann R, Yang G, Pfeifer GP. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res, 2001,61:3105-3109.

共引文献20

同被引文献102

引证文献9

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部